Alamar Biosciences, Inc.
Ticker: 2104204
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
33.55
+14.0%+68.5%
Expenditure
48.68
+13.3%+75.1%
Net Profit
-13.34
-1.1%-66.8%
OPM %
-45.13%
+0.85pp-5.53pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingALMR
202631Dec
Board Meeting
Timothy "Tod" White will retire from his position as Preside…
SEC Filing ↗ Board MeetingALMR
20261Sep
Board Meeting
Robert Ragusa appointed to the Board of Directors and its co…
SEC Filing ↗